UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SWATH mass spectrometry as a tool for quantitative profiling of the matrisome

Journal of proteomics, 2018-10, Vol.189, p.11-22

2018

Volltextzugriff (PDF)

Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors

Cell reports (Cambridge), 2016-10, Vol.17 (5), p.1265-1275

2016

Volltextzugriff (PDF)

A mouse SWATH-mass spectrometry reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts

Disease models & mechanisms, 2020-07, Vol.13 (7)

2020

Volltextzugriff (PDF)

Breast cancer heterogeneity: parallel evolution or conscious uncoupling?

The Journal of pathology, 2015-09, Vol.237 (1), p.1-3

Natrajan, Rachael C

2015

Volltextzugriff (PDF)

SF3B1 mutations constitute a novel therapeutic target in breast cancer

The Journal of pathology, 2015-03, Vol.235 (4), p.571-580

2015

Volltextzugriff (PDF)

Comparative proteomic assessment of matrisome enrichment methodologies

Biochemical journal, 2016-11, Vol.473 (21), p.3979-3995

2016

Volltextzugriff (PDF)

Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer

Oncotarget, 2016-09, Vol.7 (39), p.62939-62953

2016

Volltextzugriff (PDF)

A mouse SWATH-MS reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts

Disease models & mechanisms, 2020-01

2020

Volltextzugriff (PDF)

Abstract NTOC-093: SYNTHETIC LETHAL APPROACHES TO TARGET ARID1A DEFICIENT OVARIAN CANCERS

Clinical cancer research, 2017-06, Vol.23 (11_Supplement), p.NTOC-093-NTOC-093

2017

Volltextzugriff (PDF)

Abstract 788: Modeling tumor microenvironmental heterogeneity identifies CREBBP as a novel tumor suppressor in breast cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.788-788

2018

Volltextzugriff (PDF)

Abstract A28: Evaluation of CDK12 protein expression as a novel biomarker for PARP1/2 inhibitor sensitivity in breast cancer

Molecular cancer research, 2016-02, Vol.14 (2_Supplement), p.A28-A28

2016

Volltextzugriff (PDF)

Abstract 2138: Functional characterization of the 19q12 amplicon in grade 3 breast cancers

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2138-2138

2010

Volltextzugriff (PDF)

The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas

Clinical cancer research, 2017-07, Vol.23 (14), p.3859-3870

2017

Volltextzugriff (PDF)

An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer

Breast cancer research : BCR, 2015-09, Vol.17 (1), p.131-131, Article 131

2015

Volltextzugriff (PDF)

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

Oncogene, 2010-04, Vol.29 (14), p.2013-2023

2010

Volltextzugriff (PDF)

PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors

Science translational medicine, 2010-10, Vol.2 (53), p.53ra75

2010

Volltextzugriff (PDF)

Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers

The Journal of pathology, 2012-01, Vol.226 (1), p.84-96

2012

Volltextzugriff (PDF)

The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer

Clinical cancer research, 2018-10, Vol.24 (19), p.4763-4770

2018

Volltextzugriff (PDF)

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation

Modern pathology, 2011-02, Vol.24 (2), p.209-231

2011

Volltextzugriff (PDF)

BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells

Cell stem cell, 2010-09, Vol.7 (3), p.403-417

2010

Volltextzugriff (PDF)

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

The Journal of pathology, 2010-04, Vol.220 (5), p.562-573

2010

Volltextzugriff (PDF)

integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

Breast cancer research and treatment, 2010-06, Vol.121 (3), p.575-589

2010

Volltextzugriff (PDF)

An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer

Oncogene, 2014-05, Vol.33 (19), p.2478-2486

2014

Volltextzugriff (PDF)

Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas

Clinical cancer research, 2011-03, Vol.17 (6), p.1521-1534

2011

Volltextzugriff (PDF)

PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas

Clinical cancer research, 2009-04, Vol.15 (7), p.2269-2280

2009

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(59)

Sprache

Englisch
(59)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(50)
Humans
(49)
Female
(44)
Oncology
(34)
Breast Cancer
(33)
Breast Neoplasms - Genetics
(31)
Breast Neoplasms - Pathology
(30)
Tumors
(26)
Biological And Medical Sciences
(22)
Medical Sciences
(21)
Pathology
(20)
Mutation
(18)
Breast Neoplasms - Metabolism
(17)
Comparative Genomic Hybridization
(17)
Gynecology. Andrology. Obstetrics
(17)
Cell Line, Tumor
(15)
Mammary Gland Diseases
(15)
Genomics
(14)
Carcinoma, Ductal, Breast - Genetics
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SWATH mass spectrometry as a tool for quantitative profiling of the matrisome

Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors

A mouse SWATH-mass spectrometry reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts

Breast cancer heterogeneity: parallel evolution or conscious uncoupling?

SF3B1 mutations constitute a novel therapeutic target in breast cancer

Comparative proteomic assessment of matrisome enrichment methodologies

Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer

A mouse SWATH-MS reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts

Abstract NTOC-093: SYNTHETIC LETHAL APPROACHES TO TARGET ARID1A DEFICIENT OVARIAN CANCERS

Abstract 788: Modeling tumor microenvironmental heterogeneity identifies CREBBP as a novel tumor suppressor in breast cancer

Abstract A28: Evaluation of CDK12 protein expression as a novel biomarker for PARP1/2 inhibitor sensitivity in breast cancer

Abstract 2138: Functional characterization of the 19q12 amplicon in grade 3 breast cancers

The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas

An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors

Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers

The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer

β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation

BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer

Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas

PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas

Suchergebnisse filtern